meglumine antimoniate has been researched along with Tuberculosis, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khamesipour, A; Khatami, A; Mortazavi, H; Soori, T; Vasheghani-Farahani, A | 1 |
| Escobar, MA; Saravia, NG; Weigle, KA | 1 |
2 other study(ies) available for meglumine antimoniate and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran.
Topics: Antiprotozoal Agents; Antitubercular Agents; Child; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pleural Effusion; Polymerase Chain Reaction; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2014 |
Concurrent mucosal leishmaniasis and pulmonary tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Contraindications; Drug Therapy, Combination; Humans; Immunity, Cellular; Isoniazid; Leishmania; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1996 |